Statistics

Total Visits

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor61

Select a period of time:

Number of views in the range

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor24

Views

Views
July 202511
August 20251
September 20253
October 20250
November 20251
December 20255
January 20263
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
United Kingdom6
Brazil2
Argentina1
Bolivia1
Hong Kong1
Mexico1
Turkey1
 

Top cities views

Views
San Jose2
Ashburn2
Bluffton1
Charlotte1
Hong Kong1
Hope1
Izmir1
Nova Resende1
Philadelphia1
Poza Rica1